Nicotine Replacement Therapy Market Size, Share & Trends Report

Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report By Product, By Region, And Segment Forecasts, 2019 To 2025

  • Published Date: ---
  • Base Year for Estimate:
  • Report ID: GVR5375
  • Format: Electronic (PDF)
  • Historical Data:
  • Number of Pages: 0

The global nicotine replacement therapy market is expected to witness significant growth over the forecast period. Around the globe, the population addicted to smoking and nicotine products have risen exponentially in the past 4 decades. Changing lifestyle, hoax beliefs such as smoking provides stress relief and nicotine abuse has been the leading factor for the population up for the usage of tobacco.

Smoking leads to various health-related complications such as blockage of arteries resulting in a stroke, lung cancer, throat, or other cancers related to the respiratory system due to the presence of highly toxic carcinogens. It is estimated that in the U.S., around 480,000 people die of tobacco smoking or it causes 1 in 5 deaths in the country every year making it the leading cause of preventable death in the country.

The market for nicotine replacement therapies is fueled by the rising desire to quit smoking, and an increasing number of health companies serving anti-smoking campaigns, the introduction of novel smoking cessation products. However, the inaccurate research data to back the claims of the effectiveness of these nicotine replacement therapies is still a question mark that is being worked on. This acted as a bottleneck for the growth of the total number of industry operators & the number of approved products for these therapies.

Other factors such as the growing incidence of chronic obstructive pulmonary disease (COPD), lung cancer, asthma, various cardiac diseases, increasing awareness pertaining to the hazards of smoking is set to help the market expansion. Incentives & awareness campaigns from the governments are one more factor that is encouraging the companies to push for anti-smoking innovations.

Nicotine replacement products such as lozenges, gums, pills nicotine patches, nasal sprays have been popular tobacco replacement therapies and held a significant market in most of the regions. E-cigarettes are one more type of therapy that is being used at higher rates compared to the others. Some of the leading companies that are into nicotine replacement innovation are Cipla Ltd., Pfizer, Inc., GlaxoSmithKline plc, Novartis International AG, McNeil AB, Takeda pharmaceutical Company Ltd., Imperial Tobacco Ltd., Revolymer plc, and VMR Products, LLC.

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities